4,0
19. Aug. 2022
Aktueller Mitarbeiter
Rahway, NJ
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Large, fairly fluid organization with opportunities for career pivots into diverse areas. Significant recent investments into scientific and manufacturing capability. High degree of autonomy from management in day to day work
Kontras
Pay has not adjusted to dramatic increases in cost of living and a tightening labor market. Recent yearly salary increases, company wide, have been highly disappointing, given current labor market. Heavily beurocratic/documentation burdened, even for the pharma industry.